176 related articles for article (PubMed ID: 21465530)
1. Sp1 is a transcription repressor to stanniocalcin-1 expression in TSA-treated human colon cancer cells, HT29.
Law AY; Yeung BH; Ching LY; Wong CK
J Cell Biochem; 2011 Aug; 112(8):2089-96. PubMed ID: 21465530
[TBL] [Abstract][Full Text] [Related]
2. Histone deacetylase inhibitor-induced cellular apoptosis involves stanniocalcin-1 activation.
Law AY; Lai KP; Lui WC; Wan HT; Wong CK
Exp Cell Res; 2008 Oct; 314(16):2975-84. PubMed ID: 18652825
[TBL] [Abstract][Full Text] [Related]
3. Requirement of a specific Sp1 site for histone deacetylase-mediated repression of transforming growth factor beta Type II receptor expression in human pancreatic cancer cells.
Zhao S; Venkatasubbarao K; Li S; Freeman JW
Cancer Res; 2003 May; 63(10):2624-30. PubMed ID: 12750289
[TBL] [Abstract][Full Text] [Related]
4. Histone deacetylase inhibitors activate INK4d gene through Sp1 site in its promoter.
Yokota T; Matsuzaki Y; Miyazawa K; Zindy F; Roussel MF; Sakai T
Oncogene; 2004 Jul; 23(31):5340-9. PubMed ID: 15107822
[TBL] [Abstract][Full Text] [Related]
5. Phosphatidylinositol 3-kinase/protein kinase Czeta-induced phosphorylation of Sp1 and p107 repressor release have a critical role in histone deacetylase inhibitor-mediated derepression [corrected] of transcription of the luteinizing hormone receptor gene.
Zhang Y; Liao M; Dufau ML
Mol Cell Biol; 2006 Sep; 26(18):6748-61. PubMed ID: 16943418
[TBL] [Abstract][Full Text] [Related]
6. Trichostatin A and sirtinol suppressed survivin expression through AMPK and p38MAPK in HT29 colon cancer cells.
Hsu YF; Sheu JR; Lin CH; Yang DS; Hsiao G; Ou G; Chiu PT; Huang YH; Kuo WH; Hsu MJ
Biochim Biophys Acta; 2012 Feb; 1820(2):104-15. PubMed ID: 22155142
[TBL] [Abstract][Full Text] [Related]
7. Chromatin structure and expression of the AMPA receptor subunit Glur2 in human glioma cells: major regulatory role of REST and Sp1.
Ekici M; Keim A; Rössler OG; Hohl M; Thiel G
J Cell Biochem; 2012 Feb; 113(2):528-43. PubMed ID: 21948504
[TBL] [Abstract][Full Text] [Related]
8. Histone deacetylase inhibitor activates the WAF1/Cip1 gene promoter through the Sp1 sites.
Sowa Y; Orita T; Minamikawa S; Nakano K; Mizuno T; Nomura H; Sakai T
Biochem Biophys Res Commun; 1997 Dec; 241(1):142-50. PubMed ID: 9405248
[TBL] [Abstract][Full Text] [Related]
9. Activation of the p21WAF1/CIP1 promoter independent of p53 by the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) through the Sp1 sites.
Huang L; Sowa Y; Sakai T; Pardee AB
Oncogene; 2000 Nov; 19(50):5712-9. PubMed ID: 11126357
[TBL] [Abstract][Full Text] [Related]
10. Histone deacetylase inhibitor, Trichostatin A, activates p21WAF1/CIP1 expression through downregulation of c-myc and release of the repression of c-myc from the promoter in human cervical cancer cells.
Li H; Wu X
Biochem Biophys Res Commun; 2004 Nov; 324(2):860-7. PubMed ID: 15474507
[TBL] [Abstract][Full Text] [Related]
11. 1,25-dihydroxyvitamin D3 transcriptionally represses p45Skp2 expression via the Sp1 sites in human prostate cancer cells.
Huang YC; Hung WC
J Cell Physiol; 2006 Nov; 209(2):363-9. PubMed ID: 16883603
[TBL] [Abstract][Full Text] [Related]
12. Sodium butyrate sensitizes TRAIL-mediated apoptosis by induction of transcription from the DR5 gene promoter through Sp1 sites in colon cancer cells.
Kim YH; Park JW; Lee JY; Kwon TK
Carcinogenesis; 2004 Oct; 25(10):1813-20. PubMed ID: 15142888
[TBL] [Abstract][Full Text] [Related]
13. Competitive inhibition of histone deacetylase activity by trichostatin A and butyrate.
Sekhavat A; Sun JM; Davie JR
Biochem Cell Biol; 2007 Dec; 85(6):751-8. PubMed ID: 18059533
[TBL] [Abstract][Full Text] [Related]
14. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription.
Zhang Y; Fatima N; Dufau ML
Mol Cell Biol; 2005 Sep; 25(18):7929-39. PubMed ID: 16135786
[TBL] [Abstract][Full Text] [Related]
15. Sp1 and Sp3 transcription factors mediate trichostatin A-induced and basal expression of extracellular superoxide dismutase.
Zelko IN; Folz RJ
Free Radic Biol Med; 2004 Oct; 37(8):1256-71. PubMed ID: 15451065
[TBL] [Abstract][Full Text] [Related]
16. Synergistic effect of p53 on TSA-induced stanniocalcin 1 expression in human nasopharyngeal carcinoma cells, CNE2.
Ching LY; Yeung BH; Wong CK
J Mol Endocrinol; 2012 Jun; 48(3):241-50. PubMed ID: 22493143
[TBL] [Abstract][Full Text] [Related]
17. Sp3, but not Sp1, mediates the transcriptional activation of the p21/WAF1/Cip1 gene promoter by histone deacetylase inhibitor.
Sowa Y; Orita T; Minamikawa-Hiranabe S; Mizuno T; Nomura H; Sakai T
Cancer Res; 1999 Sep; 59(17):4266-70. PubMed ID: 10485470
[TBL] [Abstract][Full Text] [Related]
18. Trichostatin A inhibits TGF-β1 induced in vitro chondrogenesis of hMSCs through Sp1 suppression.
Wang JP; Wen MH; Chen YT; Lee HH; Chiang ER; Lee YT; Liu CL; Chen TH; Hung SC
Differentiation; 2011 Feb; 81(2):119-26. PubMed ID: 21074928
[TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase inhibitors increase human arylamine N-acetyltransferase-1 expression in human tumor cells.
Paterson S; Sin KL; Tiang JM; Minchin RF; Butcher NJ
Drug Metab Dispos; 2011 Jan; 39(1):77-82. PubMed ID: 20870783
[TBL] [Abstract][Full Text] [Related]
20. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
Lu Z; Luo RZ; Peng H; Huang M; Nishmoto A; Hunt KK; Helin K; Liao WS; Yu Y
Oncogene; 2006 Jan; 25(2):230-9. PubMed ID: 16158053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
